Exploratory inflammatory profiles in patients with depressive disorders and a history of cancer considering alcohol consumption
Journal
General Hospital Psychiatry
ISSN
0163-8343
Date Issued
2026-05-08
Author(s)
Théodore Vinais
Brigitte Plansont
Alexis Parenté
Philippe Nubukpo
Aurélie Lacroix
Editor(s)
Nakhchivan State University
Nakhchivan State University
DOI
https://doi.org/10.1016/j.genhosppsych.2026.05.007
Abstract
Purpose: Psychiatric disorders, including recurrent unipolar depression and bipolar disorder, are associated with
increased cancer risk and premature mortality. Alcohol use disorder (AUD) and immune dysregulation may
underlie these associations.
Objectives: This exploratory study investigated whether inflammatory and neuroplasticity-related biomarkers
differ according to cancer history and alcohol abstinence in patients with AUD and depressive disorders.
Methods: We conducted a retrospective analysis of 172 patients from a French clinical cohort, including 53
participants with longitudinal inflammatory and neuroplasticity biomarkers assessed over six months.
Results: Among the study sample (mean age: 45.7 years; 134 men/38 women), 12.8% had cancer history, predominantly
ear, nose and throat (27.3%) and breast cancers (22.7%), with psychiatric diagnoses preceding
cancer onset by approximately 15 years. IL-8 (Interleukin-8) levels were significantly higher in participants with
cancer history and depressive disorders, independently of alcohol abstinence, suggesting a stable cancerassociated
inflammatory signature. In contrast, TNF-α (Tumor Necrosis Factor-alpha) levels varied according
to alcohol abstinence status over time, distinguishing abstinent from non-abstinent individuals independently of
cancer history. BDNF (Brain-Derived Neurotrophic Factor) levels did not differ according to cancer history or
abstinence.
Conclusions: These findings suggest that distinct inflammatory pathways may characterize cancer history and
alcohol abstinence in patients with AUD and depressive disorders. IL-8 and TNF-α may represent candidate
biomarkers associated with cancer-associated inflammation and alcohol abstinence status, respectively. Given
the small cancer subgroup, these results should be interpreted as exploratory and hypothesis-generating. Future
studies integrating genetic, epigenetic, and molecular markers are needed to refine these associations and support
personalized approaches.
increased cancer risk and premature mortality. Alcohol use disorder (AUD) and immune dysregulation may
underlie these associations.
Objectives: This exploratory study investigated whether inflammatory and neuroplasticity-related biomarkers
differ according to cancer history and alcohol abstinence in patients with AUD and depressive disorders.
Methods: We conducted a retrospective analysis of 172 patients from a French clinical cohort, including 53
participants with longitudinal inflammatory and neuroplasticity biomarkers assessed over six months.
Results: Among the study sample (mean age: 45.7 years; 134 men/38 women), 12.8% had cancer history, predominantly
ear, nose and throat (27.3%) and breast cancers (22.7%), with psychiatric diagnoses preceding
cancer onset by approximately 15 years. IL-8 (Interleukin-8) levels were significantly higher in participants with
cancer history and depressive disorders, independently of alcohol abstinence, suggesting a stable cancerassociated
inflammatory signature. In contrast, TNF-α (Tumor Necrosis Factor-alpha) levels varied according
to alcohol abstinence status over time, distinguishing abstinent from non-abstinent individuals independently of
cancer history. BDNF (Brain-Derived Neurotrophic Factor) levels did not differ according to cancer history or
abstinence.
Conclusions: These findings suggest that distinct inflammatory pathways may characterize cancer history and
alcohol abstinence in patients with AUD and depressive disorders. IL-8 and TNF-α may represent candidate
biomarkers associated with cancer-associated inflammation and alcohol abstinence status, respectively. Given
the small cancer subgroup, these results should be interpreted as exploratory and hypothesis-generating. Future
studies integrating genetic, epigenetic, and molecular markers are needed to refine these associations and support
personalized approaches.
Subjects
File(s)![Thumbnail Image]()
Loading...
Name
1-s2.0-S0163834326001039-main.pdf
Size
629.05 KB
Format
Adobe PDF
Checksum
(MD5):5e170e45a48fa13833fd67cbdb1e8f53
